1. Mark Rossi, PhD Two Cases of Supply Chain Change: Herman Miller & Health Care Without Harm Sustainable Business and Safer Chemistry through the Supply Chain: An Innovators Roundtable

2. Opportunities herman miller Design for Environment Barriers

3. quality design Source of Graphic: Charles Eames Design Diagram (made for the 1969 Exhibition, What is Design? -- at the Musess des Arts Decoratifs, Paris) high Charles Eames “then it is in this area of overlapping interest and concern that the designer can work with conviction and enthusiasm.”

4. DfE Program –Material Chemistry –Disassembly –Recyclability DfE program Gary Miller, chief development officer, “Only by incorporating environment into design can we create value rather than cost.”

5. barriers Collecting chemical constituent data for plastics, colorants and coating finishes Evaluating the hazards of a chemical. Eliminating materials that lack an easily identifiable and cost competitive alternative Integrating significant design changes into existing products

6. opportunities Investing in high quality design pays off in the long run Shareholder concerns Customer demand

7. Health Care Without Harm -- changing the health care supply chain

8. market campaigns Health care Buildings Cosmetics Electronics Autos Retail sector - WalMart role of ngo’s

9. markets – what? Driving change in health care sector: –Chemicals & Material Selection, including PBTs, BFRs, mercury, phthalates, PVc –Chemicals policy –Waste Disposal Targeting the supply chain –Manufacturers –Group Purchasing Organizations –Health care systems, eg, Kaiser –Hospitals –Waste disposal Working with: nurses, doctors, purchasers, EHS staff, architects, designers, patient groups hcwh - creating

10. how? Collaboration / partnerships with: –Major health care systems: Kaiser, CHW, CHE, CHI –GPOs: Consorta,Broadlane, Premier, Novation –Shareholders: Tyco, Baxter, Abbott, Becton Dickinson –ANA, AHA, EPA to form Hospitals for a Healthy Environment (H2E) Providing technical support Education: conference (CleanMed), presentations, latest scientific research Regulation -- FDA Confronting market laggards